Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 61 (6) , 2025-2032
- https://doi.org/10.1046/j.1523-1755.2002.00352.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- ERK Mediates Effects of Glycated Albumin in Mesangial CellsBiochemical and Biophysical Research Communications, 2001
- Glycated albumin stimulates TGF-βbgr;1 production and protein kinase C activity in glomerular endothelial cellsKidney International, 2001
- Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β systemKidney International, 1998
- Glycated Albumin Stimulates Fibronectin and Collagen IV Production by Glomerular Endothelial Cells under Normoglycemic ConditionsBiochemical and Biophysical Research Communications, 1997
- Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcriptionMolecular and Cellular Biochemistry, 1995
- Amadori glucose adducts modulate mesangial cell growth and collagen gene expressionKidney International, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISAJournal of Immunological Methods, 1989
- Nonenzymatic Glucosylation of Serum Proteins and Hemoglobin: Response to Changes in Blood Glucose Levels in Diabetic RatsDiabetes, 1980
- Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus.Proceedings of the National Academy of Sciences, 1979